img

Global Hospital Acquired Infections Control Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Hospital Acquired Infections Control Market Research Report 2024

Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
According to MRAResearch’s new survey, global Hospital Acquired Infections Control market is projected to reach US$ 6985.5 million in 2033, increasing from US$ 5702.2 million in 2022, with the CAGR of 2.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hospital Acquired Infections Control market research.
Key companies engaged in the Hospital Acquired Infections Control industry include AstraZeneca, GlaxoSmithKline, Merck and Pfizer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Hospital Acquired Infections Control were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hospital Acquired Infections Control market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hospital Acquired Infections Control market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca
GlaxoSmithKline
Merck
Pfizer
Segment by Type
Education
Medical Device Disinfection
Screening
Environmental Control

Segment by Application


General Hospital
Infectious Disease Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hospital Acquired Infections Control report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infections Control Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Education
1.2.3 Medical Device Disinfection
1.2.4 Screening
1.2.5 Environmental Control
1.3 Market by Application
1.3.1 Global Hospital Acquired Infections Control Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 General Hospital
1.3.3 Infectious Disease Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections Control Market Perspective (2018-2033)
2.2 Hospital Acquired Infections Control Growth Trends by Region
2.2.1 Global Hospital Acquired Infections Control Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hospital Acquired Infections Control Historic Market Size by Region (2018-2023)
2.2.3 Hospital Acquired Infections Control Forecasted Market Size by Region (2024-2033)
2.3 Hospital Acquired Infections Control Market Dynamics
2.3.1 Hospital Acquired Infections Control Industry Trends
2.3.2 Hospital Acquired Infections Control Market Drivers
2.3.3 Hospital Acquired Infections Control Market Challenges
2.3.4 Hospital Acquired Infections Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections Control Players by Revenue
3.1.1 Global Top Hospital Acquired Infections Control Players by Revenue (2018-2023)
3.1.2 Global Hospital Acquired Infections Control Revenue Market Share by Players (2018-2023)
3.2 Global Hospital Acquired Infections Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infections Control Revenue
3.4 Global Hospital Acquired Infections Control Market Concentration Ratio
3.4.1 Global Hospital Acquired Infections Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections Control Revenue in 2022
3.5 Hospital Acquired Infections Control Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infections Control Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infections Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infections Control Breakdown Data by Type
4.1 Global Hospital Acquired Infections Control Historic Market Size by Type (2018-2023)
4.2 Global Hospital Acquired Infections Control Forecasted Market Size by Type (2024-2033)
5 Hospital Acquired Infections Control Breakdown Data by Application
5.1 Global Hospital Acquired Infections Control Historic Market Size by Application (2018-2023)
5.2 Global Hospital Acquired Infections Control Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hospital Acquired Infections Control Market Size (2018-2033)
6.2 North America Hospital Acquired Infections Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Hospital Acquired Infections Control Market Size by Country (2018-2023)
6.4 North America Hospital Acquired Infections Control Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Acquired Infections Control Market Size (2018-2033)
7.2 Europe Hospital Acquired Infections Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Hospital Acquired Infections Control Market Size by Country (2018-2023)
7.4 Europe Hospital Acquired Infections Control Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infections Control Market Size (2018-2033)
8.2 Asia-Pacific Hospital Acquired Infections Control Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2018-2023)
8.4 Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infections Control Market Size (2018-2033)
9.2 Latin America Hospital Acquired Infections Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Hospital Acquired Infections Control Market Size by Country (2018-2023)
9.4 Latin America Hospital Acquired Infections Control Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infections Control Market Size (2018-2033)
10.2 Middle East & Africa Hospital Acquired Infections Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2018-2023)
10.4 Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Hospital Acquired Infections Control Introduction
11.1.4 AstraZeneca Revenue in Hospital Acquired Infections Control Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Hospital Acquired Infections Control Introduction
11.2.4 GlaxoSmithKline Revenue in Hospital Acquired Infections Control Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Hospital Acquired Infections Control Introduction
11.3.4 Merck Revenue in Hospital Acquired Infections Control Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Hospital Acquired Infections Control Introduction
11.4.4 Pfizer Revenue in Hospital Acquired Infections Control Business (2018-2023)
11.4.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hospital Acquired Infections Control Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Education
Table 3. Key Players of Medical Device Disinfection
Table 4. Key Players of Screening
Table 5. Key Players of Environmental Control
Table 6. Global Hospital Acquired Infections Control Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Hospital Acquired Infections Control Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Hospital Acquired Infections Control Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Hospital Acquired Infections Control Market Share by Region (2018-2023)
Table 10. Global Hospital Acquired Infections Control Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Hospital Acquired Infections Control Market Share by Region (2024-2033)
Table 12. Hospital Acquired Infections Control Market Trends
Table 13. Hospital Acquired Infections Control Market Drivers
Table 14. Hospital Acquired Infections Control Market Challenges
Table 15. Hospital Acquired Infections Control Market Restraints
Table 16. Global Hospital Acquired Infections Control Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Hospital Acquired Infections Control Market Share by Players (2018-2023)
Table 18. Global Top Hospital Acquired Infections Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections Control as of 2022)
Table 19. Ranking of Global Top Hospital Acquired Infections Control Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Hospital Acquired Infections Control Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hospital Acquired Infections Control Product Solution and Service
Table 23. Date of Enter into Hospital Acquired Infections Control Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hospital Acquired Infections Control Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Hospital Acquired Infections Control Revenue Market Share by Type (2018-2023)
Table 27. Global Hospital Acquired Infections Control Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Hospital Acquired Infections Control Revenue Market Share by Type (2024-2033)
Table 29. Global Hospital Acquired Infections Control Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Hospital Acquired Infections Control Revenue Market Share by Application (2018-2023)
Table 31. Global Hospital Acquired Infections Control Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Hospital Acquired Infections Control Revenue Market Share by Application (2024-2033)
Table 33. North America Hospital Acquired Infections Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Hospital Acquired Infections Control Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Hospital Acquired Infections Control Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Hospital Acquired Infections Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Hospital Acquired Infections Control Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Hospital Acquired Infections Control Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Hospital Acquired Infections Control Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Hospital Acquired Infections Control Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Hospital Acquired Infections Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Hospital Acquired Infections Control Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hospital Acquired Infections Control Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Hospital Acquired Infections Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Hospital Acquired Infections Control Market Size by Country (2024-2033) & (US$ Million)
Table 48. AstraZeneca Company Detail
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Hospital Acquired Infections Control Product
Table 51. AstraZeneca Revenue in Hospital Acquired Infections Control Business (2018-2023) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. GlaxoSmithKline Company Detail
Table 54. GlaxoSmithKline Business Overview
Table 55. GlaxoSmithKline Hospital Acquired Infections Control Product
Table 56. GlaxoSmithKline Revenue in Hospital Acquired Infections Control Business (2018-2023) & (US$ Million)
Table 57. GlaxoSmithKline Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Hospital Acquired Infections Control Product
Table 61. Merck Revenue in Hospital Acquired Infections Control Business (2018-2023) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Hospital Acquired Infections Control Product
Table 66. Pfizer Revenue in Hospital Acquired Infections Control Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infections Control Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Hospital Acquired Infections Control Market Share by Type: 2022 VS 2033
Figure 3. Education Features
Figure 4. Medical Device Disinfection Features
Figure 5. Screening Features
Figure 6. Environmental Control Features
Figure 7. Global Hospital Acquired Infections Control Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Hospital Acquired Infections Control Market Share by Application: 2022 VS 2033
Figure 9. General Hospital Case Studies
Figure 10. Infectious Disease Hospital Case Studies
Figure 11. Hospital Acquired Infections Control Report Years Considered
Figure 12. Global Hospital Acquired Infections Control Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Hospital Acquired Infections Control Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Hospital Acquired Infections Control Market Share by Region: 2022 VS 2033
Figure 15. Global Hospital Acquired Infections Control Market Share by Players in 2022
Figure 16. Global Top Hospital Acquired Infections Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections Control as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Hospital Acquired Infections Control Revenue in 2022
Figure 18. North America Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Hospital Acquired Infections Control Market Share by Country (2018-2033)
Figure 20. United States Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Hospital Acquired Infections Control Market Share by Country (2018-2033)
Figure 24. Germany Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Hospital Acquired Infections Control Market Share by Region (2018-2033)
Figure 32. China Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Hospital Acquired Infections Control Market Share by Country (2018-2033)
Figure 40. Mexico Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Hospital Acquired Infections Control Market Share by Country (2018-2033)
Figure 44. Turkey Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Hospital Acquired Infections Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Hospital Acquired Infections Control Business (2018-2023)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Hospital Acquired Infections Control Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in Hospital Acquired Infections Control Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Hospital Acquired Infections Control Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed